Compare WALD & LFCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | WALD | LFCR |
|---|---|---|
| Founded | 1988 | 1986 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Package Goods/Cosmetics | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 187.3M | 190.9M |
| IPO Year | 2021 | 1996 |
| Metric | WALD | LFCR |
|---|---|---|
| Price | $1.13 | $4.14 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 3 |
| Target Price | $2.00 | ★ $6.00 |
| AVG Volume (30 Days) | ★ 257.3K | 123.7K |
| Earning Date | 03-13-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $557,559,000.00 |
| Revenue This Year | $9.89 | N/A |
| Revenue Next Year | $4.31 | $5.04 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 6.36 |
| 52 Week Low | $0.72 | $3.63 |
| 52 Week High | $3.22 | $8.98 |
| Indicator | WALD | LFCR |
|---|---|---|
| Relative Strength Index (RSI) | 27.58 | 39.54 |
| Support Level | $0.86 | $3.63 |
| Resistance Level | $1.18 | $4.88 |
| Average True Range (ATR) | 0.07 | 0.21 |
| MACD | -0.01 | -0.03 |
| Stochastic Oscillator | 16.67 | 17.50 |
Waldencast PLC is a beauty and wellness operating platform. The company is organized into two reportable segments namely Obagi Skincare and Milk Makeup. The company generates the majority of its revenue from the Obagi Medical segment. The Obagi Medical segment is engaged in developing, marketing, and selling skin health products. The Milk Makeup segment includes developing, marketing, and selling cosmetics, skincare, and other beauty products. Geographically the company generates the majority of its revenue from North America region.
Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that provides services in the development, fill, and finish of complex sterile injectable pharmaceutical products in syringes, vials, and cartridges. The group recognizes revenue in two different product categories, CDMO and HA manufacturing.